Yes, Zovirax tablets are stable at room temperature and can be carried in your hand luggage. Keep them in the original packaging and carry a copy of the prescription in case customs or airline staff request documentation.
A mild rash is common and often resolves on its own. If the rash spreads, becomes painful, or is accompanied by fever or blistering, seek medical attention promptly as it may indicate a serious drug reaction.
Both contain the same active ingredient, acyclovir, and are required to meet the same bioequivalence standards set by the MHRA. Inactive ingredients such as fillers or binders may differ, which can be relevant for patients with specific excipient allergies.
When started at the first sign of a cold sore, oral acyclovir can shorten healing time by about one to two days compared with no treatment. Early initiation (within 24 hours of symptom onset) yields the best results.
Zovirax is approved for the treatment of active shingles, not for prophylaxis. A shingles vaccine (e.g., Shingrix) is recommended for adults over 70 in the UK for prevention.
Acyclovir is minimally metabolised by the liver, so hepatic impairment usually does not require dose adjustment. However, patients with severe liver disease should still be monitored by their clinician.
Reduced urine output, swelling of the ankles or feet, sudden weight gain, and elevated blood urea nitrogen or creatinine levels are warning signs. Prompt medical evaluation is essential.
There are no known interactions between acyclovir and standard multivitamins. Nonetheless, inform your pharmacist of all supplements you use to avoid unexpected effects.
Acyclovir does not affect the efficacy of combined oral contraceptives or other hormonal methods. No dose adjustment of the contraceptive is required.
Headache is a common, generally mild side effect of many antivirals, including acyclovir. It is thought to result from transient changes in central nervous system chemistry and usually resolves without intervention.
Zovirax is a brand-name medication that contains the antiviral active ingredient acyclovir. It is supplied as oral tablets in strengths of 200 mg, 400 mg, and 800 mg. Acyclovir belongs to the antiviral class of drugs and works by inhibiting the replication of herpes viruses. In the United Kingdom, Zovirax is a prescription-only medicine (POM) and is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Acyclovir is a nucleoside analogue that mimics the natural building block guanosine. After entering a virus-infected cell, viral thymidine kinase adds a phosphate group to acyclovir, converting it into acyclovir monophosphate. Host enzymes then add two more phosphate groups, creating acyclovir triphosphate. This active form:
Because the initial phosphorylation step depends on viral thymidine kinase, acyclovir preferentially affects infected cells while sparing most healthy cells. Onset of antiviral activity can be observed within a few hours of the first dose, with peak plasma concentrations reached approximately one hour after oral ingestion. The drug’s half-life is about 2-3 hours in individuals with normal renal function, and it is eliminated primarily unchanged by the kidneys.
Zovirax is approved by the MHRA for the following indications:
These indications reflect the drug’s ability to suppress viral replication during active infection and to limit the severity and duration of symptoms.
If any of these serious symptoms develop, stop the medication and seek urgent medical care.
The exact regimen is determined by the treating clinician based on infection type, severity, and patient factors. Typical oral dosing patterns that employ the available strengths are:
These examples illustrate how the 200 mg, 400 mg, and 800 mg tablets can be combined to achieve the recommended total daily dose. The exact schedule must be prescribed by a qualified healthcare professional.
Symptoms of acyclovir overdose may include nausea, vomiting, dizziness, and decreased urine output. In severe cases, acute kidney injury can occur. Management is supportive:
For suppressive therapy, abrupt cessation is generally safe, but patients should discuss any planned stop-over with their clinician, especially if they have frequent recurrences.
This article provides educational information about Zovirax and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
